Inclusion of HBCDD, DEHP, BBP, DBP and additive use of TBBPA in annex IV of the Commission's recast proposal of the RoHS Directive

Table 2.5
Summary of persistence, bioaccumulation potential and toxicity information for HBCDD and selected potential alternatives (Based on Washington State, 2006)

Substance Human health A/M
ecotoxicity.
Acute or
chronic
Persis-
tence
Bioacc. PBT
  Cancer
hazard
Non-
cancer
effects
Muta-
genity
Amount
of tox info
Inf on
poten-
tial
routes
of expo-
sure
HBCDD L (NI) NI L L Yes L-H Yes Yes Yes
Antimony trioxide (often used together with HBCDD) L-M L M-H M-H Yes L-M NI NI Maybe
(NI
TetrabromobisphenolA,Bis(2,3-dibromopropyl ether) M L H L NI NI NI Yes NI
Ethane-1,2-bis(pentabromophenyl) L L L L Yes L NI
(likely)
No No
Ethylenebis(tetra-bromophtalimide L L L L NI L NI
(likely)
No No
Resorcinol bis (diphenylphosphate) (RDP) NI L L L NI M-H No No No
Bisphenol A diphosphate (BAPP, BPADP) or Bisphenol A bis(diphenyl phosphate) (BDP) NI L L L NI L-M Yes NI NI
Diphenyl cresyl phosphate (DCP) NI M L L-M Yes M-H Yes Yes Maybe
(NI)
Triphenyl phosphate (TPP) L L-M L L-M Yes M-H No No No

NI : No Information/insufficient information
A/M : Aquatic and microbial
PBT: whether the alternative meets Washington State Department of Health’s PBT criteria,
Ranking: H = high, M = medium, L = low concern based on available information: Ranking is based on US EPA, 2005.

 



Version 1.0 March 2010, © Danish Environmental Protection Agency